FLT3 and leukemia: FLT3-ITD lead to receptor dimerization and ligand-independent constitutive activation of downstream signal transduction pathways, such as mitogen-activated protein kinase (MAPK) signal transducer and activator of transcription 5 (STAT5), which maintain the leukemia cells proliferation [4–6].